Sponsor Pipeline

Amylyx Pharmaceuticals Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
1
Recruiting
2
Phase 3
1
Disease Areas
Active Trials by Phase
Phase 3
2
Phase 2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05021536 Phase III Trial of AMX0035 for Amyotrophic Lateral Sclerosis Treatment Amyotrophic Lateral Sclerosis Active, Not Recruiting
NCT06747468 Avexitide for Treatment of Post-Bariatric Hypoglycemia Post Bariatric Hypoglycemia Active, Not Recruiting
Phase 2
NCT05676034 AMX0035 in Adult Patients With Wolfram Syndrome Wolfram Syndrome Active, Not Recruiting
Phase 1
NCT06665165 AMX0114 in Adult Participants With Amyotrophic Lateral Sclerosis ALS Recruiting
Disease Areas
ALS (2)
Get alerts when Amylyx Pharmaceuticals Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free